celastrol has been researched along with Bright Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Z; Fu, Y; Guo, L; Huang, Y; Li, P; Luo, S; Sun, X; Zhang, Z; Zhou, M | 1 |
1 other study(ies) available for celastrol and Bright Disease
| Article | Year |
|---|---|
Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis.
Topics: Albumins; Animals; Anti-Inflammatory Agents; Cell Line; Drug Delivery Systems; Glomerular Mesangium; Glomerulonephritis; Mesangial Cells; Nanoparticles; Pentacyclic Triterpenes; Rats; Triterpenes | 2017 |